Future-facing Uvence is innovating for the future of your face.
The biotech market is growing, as coverage on Longevity.Technology evidences. The ripples of biotech innovation are spreading into all sorts of sectors, including those that at first glance might seem like less than natural bedfellows, such as the cosmetics industry: One company fusing science with skin health is Uvence.
Advanced cosmetic science is a growing longevity industry domain area one that aligns: who wants to work hard on reducing their metabolic age while looking like their chronological age? Not many we suspect.
Longevity.Technology: Improving skin health has therapeutic benefits as well as cosmetic ones. Uvence is regulated by Human Tissue Authority for cosmetic applications, as well as treatment of scars, burns and other skin imperfections; rather than relying on synthetic substances and neurotoxins, such as Botox, the Uvence procedure relies on purified human tissue and the patient’s own cells, which significantly reduces the possibility of rejection or adverse side effects. Just like OneSkin, whose senotherapeutic skin cream proved so popular upon launch that it sold out, Uvence has realised that dermal health is more than skin deep.
Hoping to transform the face of cosmetic treatments in the UK, is Uvence’s nano-fat transfer. Dubbed ‘plastic surgery in a box’ due to its ease of application, the Uvence procedure combines minimally invasive nano-fat transfer with cryopreservation of tissue, meaning on-demand rejuvenative cosmetic treatment can be available to patients for up to five years after the initial extraction procedure.
Typically, similar nano-fat treatments are only available as one-off procedures from around 400 plastic surgeons in the UK; however, Uvence’s approach to storing and scaling such a procedure opens up this style of treatment to almost 15,000 cosmetic doctors and GPs across the country, providing a far greater level of access to cutting-edge skin repair and rejuvenation technology for patients.
Uvence creates its personalised products from a patient’s own fat cells, which are extracted by an initial micro- or mini-liposuction. The adipose tissue is filtered to a standardised level and once purified, a patient’s “super enriched tissue” can then be stored for up to five years in a regulated Uvence cryopreservation facility. This gives patients and their doctors the option to have multiple treatments from a single extraction over many years, either as follow on treatments or targeting different areas for rejuvenation.
Uvence reports that the cryopreservation, standardisation and scalability of this product has been six years in the making and should allow for a greater number of cosmetic professionals (including cosmetic doctors and dermatologists and dentists) to achieve reliable results with nano-fat injection.
“It is hugely exciting to see the next step in standardisation and quality for this kind of treatment, as Uvence allows cosmetic doctors and clinics across the country to offer a high-end regenerative cosmetic procedure in their arsenal of treatments, thereby opening up a whole new sector of the market and a new influx of patients,” commented plastic surgeon and CMO of Uvence, Dr Olivier Amar.
“Uvence is a major breakthrough for the cosmetic treatment industry, eliminating the need for synthetic substances and instead focusing on the rejuvenation powers of our own bodies.”
“The Uvence offering allows access to regenerative and personalised treatments and is the biggest advance in the field for nearly 15 years. In terms of accessibility and convenience this has never been seen before – the treatment can be carried out within 30 minutes with no recovery time, and, the cryopreservation capability allows plastic and cosmetic surgeons alike to provide this treatment on a consistent basis to their patients without the need for further liposuction or tissue extraction.”
Reece Tomlinson, CEO and co-founder of Uvence, added: “We have been aware, for some time now, of the rapid growth of the beauty industry during recent years. Since the outbreak of Covid-19, and with many people having culture changes such as working from home, the beauty industry’s growth has sped up at an exponential rate. The first ‘Zoom Boom’ boosted the cosmetic treatment arena and the wider beauty industry massively – now, with the changes in work and lifestyle brought about by the pandemic seemingly here to stay for some time, there is ample opportunity for new technologies and approaches to flourish.
“With this in mind, Uvence launched our innovative new approach to cosmetic treatments to considerable success, in an innovative industry which, rather than being negatively impacted by a global crisis, is continuing to grow. As more people deem cosmetic treatments as an essential purchase, the opportunity to present a natural alternative is prominent.
“Uvence is a major breakthrough for the cosmetic treatment industry, eliminating the need for synthetic substances and instead focusing on the rejuvenation powers of our own bodies. Our success in standardising, storing and scaling such an innovative and effective treatment is ground-breaking and changes the landscape of the cosmetic treatments industry, as patients everywhere will soon be able to access treatments previously reserved for the smallest handful of incredibly fortunate individuals. I am incredibly excited to be part of this innovative approach to beauty, and I believe that the industry is set to see more growth over the coming years.”
Longevity.Technology’s market report on this sector “Advanced cosmetics – Where longevity science and aesthetics meet” will be published in October 2021. Pre-order your copy now!
